Here we report the case of a 50-year-old woman presenting with weight gain, whole-body edema, and massive ascites. Blood examination revealed primary hypothyroidism with TSH-blocking antibody, and the echocardiogram showed diffuse hypokinesis of the left ventricle with pericardial effusion. Although she received thyroid hormone replacement therapy immediately, her ascites increased and she developed type II respiratory failure requiring transient noninvasive positive pressure ventilation (NIPPV). She recovered following the temporary drainage of the ascites, administration of diuretics, and continuous thyroid hormone replacement. The amount of ascites decreased during therapy, along with an increase in thyroid hormone levels. Finally, the ascites disappeared completely, followed by the normalization of the cardiac wall motion. Herein we report this rare case in detail, and also discuss the mechanism by which primary hypothyroidism induced such severe conditions in our patient.
Introduction
Hypothyroidism caused by autoimmune thyroiditis is a common endocrine disease especially in women. Such cases are predominantly Hashimoto's thyroiditis with goiter, but a few lack the goiter and are known as atrophic thyroiditis or idiopathic myxedema, in which the TSH receptor antibody (TRAb) and TSH-stimulation blocking antibody (TSBAb) are often detected in the serum (1) . Patients with hypothyroidism and TSBAb, which blocks TSH-stimulation of the thyroid glands, tend to suffer from severe hypothyroidism.
Severe and continuous hypothyroidism may lead to myxedema, an extreme manifestation of hypothyroidism, presenting non-pitting edema, weight gain, constipation, fatigue, cold intolerance, sparse hair, and rarely is complicated by the accumulation of fluid in vital body cavities: pericardial effusion, pleural effusion, and ascites (2) . Myxedema ascites appear in fewer than 4% of patients with hypothyroidism (3) , and are promptly reduced with thyroid hormone replacement according to previous reports (4) (5) (6) (7) (8) (9) .
Here, we report the case of a patient with refractory hypothyroidism due to idiopathic myxedema with TSBAb, presenting with large amounts of ascites, and subsequently complicated by respiratory and cardiac failure. She was placed transiently on noninvasive positive pressure ventilation (NIPPV), and recovered with the temporary drainage of the ascites, administration of diuretics, and continuous thyroid hormone replacement. The amount of ascites decreased during therapy, along with an increase in thyroid hormone levels.
Case Report
A 50-year-old woman presenting with abdominal distention and dyspnea was transferred to our hospital. She had noticed whole-body edema and weight gain of about 20 kg over the previous 1 year. She had been attending a psychiatry clinic because of schizophrenia since approximately 10 years earlier, and was treated with haloperidol and trihexyphenidyl hydrochloride. (Lithium had not been prescribed.) Her thyroid function had not been assessed previ- ously. On admission, she was alert and oriented with a hoarse voice. She was 150 cm tall and weighed 80.7 kg. Blood pressure was 187/120 mmHg, temperature 36.2 , pulse 54 beats per minute, respiratory rate 16 breaths per minute, and oxygen saturation 100% while the patient was breathing oxygen at a flow rate of 2 liters per minute through a nasal cannula. Physical examination revealed facial edema with sparse hair and eyebrows. Her thyroid was not palpable. The heart sounds were distant with a regular rhythm and breath sounds were diminished in the lower chest. The abdomen was markedly distended, with umbilical protrusion and a waist circumference of 136 cm. She had dry skin with pretibial non-pitting edema.
T a b l e 1 . L a b o r a t o r y Da t a o n Ad mi s s i o n
The results of laboratory examinations are shown in Table 1. Peripheral blood tests showed normocytic anemia and a slightly decreased level of serum sodium, without elevations in creatinine kinase or total cholesterol. Examination of serum tumor markers showed an extremely elevated carbohydrate antigen 125 (CA125) level (394 U/mL), whereas the CEA level was slightly elevated (9.8 ng/mL). Thyroid function tests demonstrated a profoundly elevated level of TSH (117.48 μIU/mL) with very low levels of Free T4 (< 0.40 ng/dL) and Free T3 (<1.00 pg/mL). Thyroid antibody measurement showed high thyroid peroxidase antibody titers (>50.0 U/mL), TRAb (89.2%), as well as TSBAb (98.2%) ( Table 2 ). Samples of ascites showed an elevated total protein level with a low serum-ascites albumin gradient (SAAG). CA125 in the ascites was markedly elevated (644 U/mL) as ob-
F i g u r e 1 . Co mp u t e d t o mo g r a p h y o f t h e c h e s t a n d a b d o me n o n a d mi s s i o n s h o w ma s s i v e a s c i t e s wi t h b i l a t e r a l e l e v a t i o n o f t h e d i a p h r a g m a n d u mb i l i c a l p r o t r u s i o n .
served in the serum. The white blood cell count in the fluid was 110/μL, comprising mainly macrophages (93%). Bacterial and mycobacterial culture and cytology were all negative ( Table 2 ).
An electrocardiogram revealed sinus bradycardia and low voltage in the limb leads. Chest X ray showed cardiomegaly and pleural effusion, while an echocardiogram revealed diffuse hypokinesis of the left ventricle (the ejection fraction was 42%) with pericardial effusion. Ultrasonographs of the thyroid showed a normal sized gland with heterogeneous and coarse echogenicity. Abdominal computed tomography (CT) demonstrated massive ascites with bilateral elevation of the diaphragm and umbilical protrusion, accompanied by squeezing of the abdominal viscera (Fig. 1) . Gynecological examination excluded ovarian carcinoma.
The patient's clinical course is shown in Fig. 2 . Because of the possibility of complicated adrenal insufficiency, physiological steroid replacement (dexamethasone 0.5 mg daily) was administered immediately preceding thyroid hormone replacement until the hormonal examination demonstrated normal adrenal function. The oral administration of levothyroxine was started with an initial dose of 25 μg daily. Since the echocardiogram revealed left ventricular dysfunction with a slightly elevated BNP level (46.5 pg/mL), intravenous administration of furosemide was combined with hormonal replacement for the possible involvement of congestive heart failure.
Although the dosage of levothyroxine was gradually increased, blood analysis identified no elevations in serum Free T4 and T3, with a deterioration in whole-body edema and ascites. After admission, the patient developed progressive respiratory failure. On the 10th hospital day, an arterial blood gas analysis revealed an aggravation of type II respiratory failure: hypoxemia (52.4 mmHg) and hypercapnia (62.4 mmHg) at an oxygen flow rate of 10 liters per minute by mask. Therefore, she was immediately placed on NIPPV. Because a repeat chest X ray showed a remarkable increase in bilateral effusion with an elevation of the diaphragm secondary to the accumulation ascites (Fig. 3) , ascitic drainage of 3 liters daily was performed for three days with an increasing dose of furosemide. Because oral administration became impossible due to complaints of nausea and aphasia, levothyroxine was administered via suppository under NIPPV and increased to a maximum of 300 μg daily.
Along with the decrease in ascites after drainage, her respiratory state ameliorated gradually and NIPPV was withdrawn on the 12th hospital day. Oral administration of levothyroxine was resumed in place of the suppository. The abdominal distension and whole-body edema subsequently decreased, and oxygen supply was discontinued with the resolution of pleural effusions. Seven weeks after admission, free T4 and T3 levels reached reference ranges at an oral dosage of 150 μg levothyroxine daily. Consequently, she was transferred to a rehabilitation hospital on the 52nd hospital day, and closely followed by outpatient examinations. Four months after admission (two months after the normalization of serum thyroid hormone levels), CT demonstrated a complete disappearance of the pericardial effusion and ascites (Fig. 4) with a normalization in the serum CA 125 level (15.6 U/mL), and profound decreases in her weight and abdominal circumference (48 kg and 70 cm, respectively). Echocardiogram revealed a resolution of sustained diffuse hypokinesis of the left ventricule: the ejection fraction was 62% six months after admission, and the furosemide was discontinued.
Discussion
In the present case, the patient presented with massive ascites considered due to idiopathic myxedema. Myxedema ascites are extremely rare, so it is necessary to distinguish from ascites caused by other disorders: liver disease, renal dysfunction, pancreatic disorders, heart failure, portal hypertension, hypoalbuminemia, infection, and malignancy. At : discharge
F i g u r e 2 . Cl i n i c a l c o u r s e . Va r i a t i o n s i n f r e e t r i i o d o t h y r o n i n e : F T 3 ( ○ ) , t h y r o x i n e : F T 4 ( ▲ ) , a n d a b d o mi n a l c i r c u mf e r e n c e ( • ) a r e s h o wn .

F i g u r e 3 . Ch e s t X r a y o n t h e 1 0 t h h o s p i t a l d a y s h o we d a r e ma r k a b l e i n c r e a s e i n b i l a t e r a l e f f u s i o n wi t h e l e v a t i o n o f t h e d i a p h r a g m c o n s i d e r e d s e c o n d a r y t o a s c i t e s a c c u mu l a t i o n .
differential diagnosis, not only imaging examination but also analysis of the ascitic fluid is useful. SAAG, which is determined by subtracting the ascites albumin level from the serum albumin level, has been shown in prospective studies to be a better discriminant than the older criterion (transudate versus exudate). SAAG is generally low (<1.1 g/dL) in ascites with infection and malignancy, and high (>1.1 g/dL) in the case of liver cirrhosis, congestive heart failure and portal hypertension. There are a few reports of SAAG values in myxedema ascites. de Castro et al (10) reported that SAAG values tend to exceed 1.1 g/dL in myxedema ascites based on a review of eight patients, in which only one case presented a gradient less than 1.1 g/dL as was found in our case. Otherwise, ascitic fluid with myxedema has been described as exudates (total protein>2.5 g/dL) in almost all cases, and these disappear rapidly after the start of thyroid hormone replacement (6) . Hypothyroidism is assumed to cause an increase in capillary permeability, followed by the escape of protein-rich fluid into the extravascular component and produce ascites with the above-mentioned properties (11). The serum CA 125 level, a well-established tumor marker of epithelial ovarian carcinoma, is also elevated in the pathology of ascites due to nonmalignant diseases such as liver cirrhosis, peritoneal tuberculosis, and myxedema ascites (7) (8) (9) . It is known that CA125 is produced not only by malignant cells, but also by the normal epithelial cells of the peritoneum (12) , and it may increase as a nonspecific response to the presence of fluid in the peritoneal cavity (7) . In fact, the ascites sample from our patient showed a high CA125 level in accordance with the elevated serum level, and the serum CA125 level decreased along with the decline in ascites and normalized concomitantly with the resolution of ascites.
Our patient presented refractory hypothyroidism even after thyroid hormone replacement, and consequently suffered from type II respiratory failure. Profound hypothyroidism may cause respiratory failure due to pleural effusions, impaired ventilatory responses to hypoxia and hypercapnia, Co mp u t e d t o mo g r a p h y o f t h e c h e s t a n d a b d o me n f o u r mo n t h s a f t e r a d mi s s i o n s h o w  i n g a c o mp l e t e d i s a p p e a r a n c e o f p e r i c a r d i a l e f f u s i o n a n d a s c i t e s . neuromuscular dysfunction, hypoventilation and obstructive sleep apnea (13) . In our patient, the accumulation of ascites contributed to respiratory failure by impairing the movement of the diaphragm.
In addition, the involvement of congestive heart failure should be suggested in our case. The previous literature on potential cardiac involvement in hypothyroidism indicate ischemic heart disease, irreversible myocardial fibrosis (14) , cardiac tamponade with pericardial effusion (15) , and reversible cardiac dysfunction (16) . In the present case, an echocardiogram on admission revealed diffuse hypokinesis of the left ventricule with moderate pericardial effusion, but an absence of image findings that would indicate cardiac tamponade: left ventricular collapse and restriction on filling of the cardiac chambers. Since the abnormalities in the left ventricular wall motion went into complete remission after the normalization of thyroid function, reversible cardiomyopathy caused by hypothyroidism might have existed at first in our case.
Since the patient complained of nausea and aphagia under NIPPV, oral administration of levothyroxine had to be discontinued. Although previous studies recommend intravenous administration as the most certain and safest route, especially for the treatment of myxedema coma, a levothyroxine solution for injection has not been marketed in Japan, and the preparation of an original drug solution with informed consent is necessary in each case. Thus, we transiently tried rectal administration via suppository instead of oral treatment. The utility of rectal administration of levothyroxine has been reported in a few cases (17) . The dosage via suppository reported for the maintenance of thyroid function is about two or three times that of the oral route, presumably because of inadequate absorption via the rectum besides and the effects of constipation and diarrhea. Similarly, in our case, no elevation in thyroid hormone levels was evident even after the administration of 300 μg daily via suppository, although it might have been effective, to some extent, since her respiratory state ameliorated and TSH level decreased.
In conclusion, the present case of myxedema ascites due to idiopathic myxedema presented refractory hypothyroidism despite thyroid hormone replacement, which later led to type II respiratory failure requiring the transient use of NIPPV. Although myxedema ascites has been regarded as rare but easily treated with thyroid hormone replacement, our case suggests that the condition can become a life-threatening if the refractory ascites are too massive and other complications due to hypothyroidism exist. Consequently, in patients with myxedema ascites, it is desirable that a diagnosis be made promptly, followed by an appropriate treatment to normalize thyroid function as quickly as possible.
